Merck (MRK) FCF Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Merck (MRK) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 1,832.00 |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 1,733.00 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | -176.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 1,592.00 |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | -2,476.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 874.00 |
| Mar 31, 2026 | 1,568.00 |
| Dec 31, 2025 | -1,260.00 |
| Sep 30, 2025 | 964.00 |
| Jun 30, 2025 | -574.00 |
| Mar 31, 2025 | -1,621.00 |
| Dec 31, 2024 | -1,266.00 |
| Sep 30, 2024 | 2,352.00 |
| Jun 30, 2024 | 2,127.00 |
| Mar 31, 2024 | 1,264.00 |
| Dec 31, 2023 | -2,315.00 |
| Sep 30, 2023 | 3,098.00 |
| Jun 30, 2023 | 377.00 |
| Mar 31, 2023 | 461.00 |
| Dec 31, 2022 | 4,289.00 |
| Sep 30, 2022 | 357.00 |
| Jun 30, 2022 | 217.00 |
| Mar 31, 2022 | 1,690.00 |
| Dec 31, 2021 | 453.00 |
| Sep 30, 2021 | 773.00 |